Safety and efficacy of MIKE-1 in patients with advanced pancreatic cancer: A study protocol for an open-label phase I/ II investigator-initiated clinical trial based on a drug repositioning approach that reprograms the tumour stroma

Định dạng: PDF / Số trang: 11

Nhắn tin với admin nếu không tải được